Sana Biotechnology Inc (SANA)

NASDAQ

$3.14

Sana Biotechnology, Inc., a biotechnology company, focuses on the use of modified cells as medicines. The company is headquartered in Seattle, Washington.

Website: https://www.sana.com

Sector:

Healthcare

Industry:

Biotechnology

68 analysts

Buy

Target: $8.57 (+172.93%)

Market Cap

$958M

Free Cash Flow Yield

-13.98%

Beta (5Y)

1.98

Price Chart

Adjust inflation

Log

Valuation

Market Cap$958M

P/B8.34

Profitability

EBITDA-$237M

EPS-$0.96

Financial Health

Free Cash Flow Yield-13.98%

Growth & Risk

FCF 5Y CAGR-6.10%

Beta (5Y)1.98

Sharpe Ratio0.03